Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Bacteroides xylanisolvens DSM 23964 |
?
Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFa-specific antibodies in human adults. Beneficial microbes (Benef Microbes ) Vol: 7 Issue 4 Pages: 485-500 Pub: 2016 Sep Epub: 2016 Apr 6 Authors Ulsemer P , Toutounian K , Kressel G , Goletz C , Schmidt J , Karsten U , Hahn A , Goletz S , Publication |
| Bacteroides xylanisolvens DSM 23964 |
?
Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults. Beneficial microbes (Benef Microbes ) Vol: 3 Issue 2 Pages: 99-111 Pub: 2012 Jun 1 Epub: Authors Ulsemer P , Toutounian K , Kressel G , Schmidt J , Karsten U , Hahn A , Goletz S , Publication |
| Bacteroides xylanisolvens DSM 23964 |
?
Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate. Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 78 Issue 2 Pages: 528-35 Pub: 2012 Jan Epub: 2011 Nov 18 Authors Ulsemer P , Toutounian K , Schmidt J , Karsten U , Goletz S , Html Article Publication |
| Bacteroides xylanisolvens DSM 23964 |
?
Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964. Regulatory toxicology and pharmacology : RTP (Regul Toxicol Pharmacol ) Vol: 62 Issue 2 Pages: 336-46 Pub: 2012 Mar Epub: 2011 Nov 6 Authors Ulsemer P , Toutounian K , Schmidt J , Leuschner J , Karsten U , Goletz S , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.